As mega deals continue to dominate headlines in 2015, there appears to be no end in sight for healthcare and life sciences companies’ appetite for acquisitions.

What are the main drivers behind the sector’s pursuit for cross-border deals, the challenges faced in executing those deals and how may advances in personalized medicine change the face of the industry?

Join us for an informal, interactive discussion over lunch to network with industry peers and discuss the results of our recent report which has been produced in partnership with Mergermarket.